Please login to the form below

Not currently logged in
Email:
Password:

Relovair

This page shows the latest Relovair news and features for those working in and with pharma, biotech and healthcare.

COPD-asthma market to reach $47bn in 2017

These medicines include SkyePharma's Flutiform (fluticasone/formoterol) to treat asthma, Novartis' Arcapta Neohaler for patients with COPD, and GSK's own Seretide follow-up Relvar (formerly Relovair) for both asthma

Latest news

More from news
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Interview: Deepak Khanna, ABPI Interview: Deepak Khanna, ABPI

    Referencing a 'real-world' study into GlaxoSmithKline's (GSK) Relovair in Salford, he says: “ We have a good example where the NHS partnered with three companies to focus on COPD.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics